A new report finds there are fewer antibacterial medicines in clinical pipelines than just two years ago and relatively few ...

President Trump announced that Pfizer agreed to offer lower prices on its drugs to the Medicaid program and directly to ...

WASHINGTON — President Trump told pharmaceutical companies last week that they should start building infrastructure in the ...

Researchers have found that ALS patients have autoimmune responses, a finding with the potential to reshape how scientists ...

Patient groups urge U.K.’s antitrust regulator to investigate drugmakers for “suspected” and “coordinated” efforts to drive ...

Good morning. The government is shut down, but the First Opinion Podcast is back. Take a listen.

STAT spoke with Robert Hendren, a retired UCSF researcher who conducted a small study of leucovorin in children with autism ...

I'm never going to speak to everyone. We need a much greater diversity of science communicators and researchers and experts ...

The only way for work requirements to shrink the Medicaid rolls by inducing people to work is to get them to take jobs that ...

A new study found that an AI “safety net” reduced diagnostic errors by 16% and treatment errors by 13% — but also created new ...

Morning. Today, we go deep on the drug-pricing deal Pfizer has struck with President Trump, hear from an expert on leucovorin ...